Valued at $15.0M at its seed round, Aug 2024. Nothing has traded since.
- ·The complete investor list: 12 names
- ·Watch Kano Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Kano Therapeutics funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2024 | Seed Round | $5.0M | ▮ | ▮ |
| May 2022 | Seed Round | $2.1M | ▮ | ▮ |
Membership and data by Private Market View
Kano Therapeutics valuation
Kano Therapeutics was valued at $15 million at its seed round in Aug 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Kano Therapeutics raised?
Kano Therapeutics has raised $7.4 million across 2 recorded rounds since 2022. The largest was a $5 million seed round in Aug 2024.
Kano Therapeutics has filed 1 Form D with the SEC, most recently in May 2024 ($5 million sold to 4 investors).
Comparable companies
Comparable biotechnology names by valuation on PrivateMarketView: Azalea Therapeutics ($153 million), KaloCyte ($24.7 million) and Industrial Microbes ($24 million).
How Kano Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Kano Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Kano Therapeutics
- What is Kano Therapeutics worth?
- Kano Therapeutics is valued at $15.0M as of Oct 2026. Valued at $15.0M at its seed round, Aug 2024. Nothing has traded since.
- How much has Kano Therapeutics raised?
- Kano Therapeutics has raised $7.4M in total funding across 2 recorded rounds.
- When did Kano Therapeutics last raise?
- Kano Therapeutics last raised in Aug 2024 (Seed Round), raising $5.0M.